Compare BSET & LUCD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BSET | LUCD |
|---|---|---|
| Founded | 1902 | 2018 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Home Furnishings | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 153.2M | 159.9M |
| IPO Year | 1995 | 2021 |
| Metric | BSET | LUCD |
|---|---|---|
| Price | $14.93 | $1.45 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $3.94 |
| AVG Volume (30 Days) | 20.1K | ★ 781.6K |
| Earning Date | 05-06-2026 | 01-01-0001 |
| Dividend Yield | ★ 5.37% | N/A |
| EPS Growth | ★ 163.06 | 16.67 |
| EPS | ★ 0.70 | N/A |
| Revenue | ★ $456,855,000.00 | $4,346,000.00 |
| Revenue This Year | $4.63 | $7.69 |
| Revenue Next Year | $4.34 | $155.47 |
| P/E Ratio | $21.37 | ★ N/A |
| Revenue Growth | 0.96 | ★ 79.00 |
| 52 Week Low | $13.96 | $0.95 |
| 52 Week High | $19.75 | $1.80 |
| Indicator | BSET | LUCD |
|---|---|---|
| Relative Strength Index (RSI) | 42.20 | 64.46 |
| Support Level | $14.55 | $1.01 |
| Resistance Level | $17.29 | $1.53 |
| Average True Range (ATR) | 0.56 | 0.08 |
| MACD | -0.02 | 0.01 |
| Stochastic Oscillator | 26.52 | 84.29 |
Bassett Furniture Industries Inc is a manufacturer, marketer, and retailer of home furnishings products in the United States. It operates through the following segments: The Wholesale segment focuses on the design, manufacture, sourcing, sale, and distribution of furniture products, the Retail segment which consists of company-owned stores, and the Corporate and others segment. Majority of revenue is from Wholesale sales of furniture and accessories.
Lucid Diagnostics Inc is a commercial-stage medical diagnostics technology company focused on the millions of patients with gastroesophageal reflux disease (GERD), also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically lethal esophageal adenocarcinoma. Its products include EsoCheck and EsoGuard.